Prospective Longitudinal Evaluation of Coagulation with Novel Thromboelastography Technology in Patients after Subarachnoid Hemorrhage - A Pilot Study

Not Applicable

• Conditions: Subarachnoid haemorrhage; Hypercoagulability; Blood - Clotting disorders

• Registration Number: ACTRN12615000777594
• Lead Sponsor: Dr Khaled El-Khawas

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-07-27
• Study Completion: 2017-09-30
• Last Update Posted: 9 August 2022

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 14

Inclusion Criteria

Adult patients (aged 18 years or older)
- We will include patients who are diagnosed with subarachnoid haemorrhage based on the following criteria
1.CT brain (non contrast, contrast or infusion) showing bleeding.
2.Digital Subtraction cerebral angiography.
3.MRI Brain, MRA
4.Positive Lumbar puncture with CSF analysis if CT head negative post 6 hours of presentation.

Exclusion Criteria

Traumatic causes of SAH
Refusal to consent for enrolment of the study.
Unable to obtain consent from self or relative.
Death is expected within the next 24 hours.

Study & Design

• Study Type: Observational
• Study Design: Not specified